Report Detail
Global Xerostomia (Dry Mouth) Therapeutics Market Insights, Forecast to 2025
- RnM2441246 |
- 12 April, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The global Xerostomia (Dry Mouth) Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Xerostomia (Dry Mouth) Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Xerostomia (Dry Mouth) Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Xerostomia (Dry Mouth) Therapeutics in these regions.
This research report categorizes the global Xerostomia (Dry Mouth) Therapeutics market by top players/brands, region, type and end user. This report also studies the global Xerostomia (Dry Mouth) Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline plc
Church & Dwight Co., Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Market size by Product
Salivary Stimulants
Salivary Substitutes
Dentifrices
Market size by End User
OTC
Prescription
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Xerostomia (Dry Mouth) Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Xerostomia (Dry Mouth) Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Xerostomia (Dry Mouth) Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Xerostomia (Dry Mouth) Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Xerostomia (Dry Mouth) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Xerostomia (Dry Mouth) Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Xerostomia (Dry Mouth) Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Product
- 1.4.2 Salivary Stimulants
- 1.4.3 Salivary Substitutes
- 1.4.4 Dentifrices
- 1.5 Market by End User
- 1.5.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by End User
- 1.5.2 OTC
- 1.5.3 Prescription
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size
- 2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue 2014-2025
- 2.1.2 Global Xerostomia (Dry Mouth) Therapeutics Sales 2014-2025
- 2.2 Xerostomia (Dry Mouth) Therapeutics Growth Rate by Regions
- 2.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Regions
- 2.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers
- 3.1.1 Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers
- 3.1.2 Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Xerostomia (Dry Mouth) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers
- 3.2.1 Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Xerostomia (Dry Mouth) Therapeutics Price by Manufacturers
- 3.4 Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Xerostomia (Dry Mouth) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Xerostomia (Dry Mouth) Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Product
- 4.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Product
- 4.3 Xerostomia (Dry Mouth) Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Xerostomia (Dry Mouth) Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Xerostomia (Dry Mouth) Therapeutics by Countries
- 6.1.1 North America Xerostomia (Dry Mouth) Therapeutics Sales by Countries
- 6.1.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Xerostomia (Dry Mouth) Therapeutics by Product
- 6.3 North America Xerostomia (Dry Mouth) Therapeutics by End User
7 Europe
- 7.1 Europe Xerostomia (Dry Mouth) Therapeutics by Countries
- 7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Countries
- 7.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Xerostomia (Dry Mouth) Therapeutics by Product
- 7.3 Europe Xerostomia (Dry Mouth) Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Xerostomia (Dry Mouth) Therapeutics by Countries
- 8.1.1 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Xerostomia (Dry Mouth) Therapeutics by Product
- 8.3 Asia Pacific Xerostomia (Dry Mouth) Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Xerostomia (Dry Mouth) Therapeutics by Countries
- 9.1.1 Central & South America Xerostomia (Dry Mouth) Therapeutics Sales by Countries
- 9.1.2 Central & South America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Xerostomia (Dry Mouth) Therapeutics by Product
- 9.3 Central & South America Xerostomia (Dry Mouth) Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics by Countries
- 10.1.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics by Product
- 10.3 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics by End User
11 Company Profiles
- 11.1 GlaxoSmithKline plc
- 11.1.1 GlaxoSmithKline plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.1.5 GlaxoSmithKline plc Recent Development
- 11.2 Church & Dwight Co., Inc.
- 11.2.1 Church & Dwight Co., Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.2.5 Church & Dwight Co., Inc. Recent Development
- 11.3 Colgate-Palmolive Company
- 11.3.1 Colgate-Palmolive Company Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.3.5 Colgate-Palmolive Company Recent Development
- 11.4 Hikma Pharmaceuticals PLC
- 11.4.1 Hikma Pharmaceuticals PLC Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.4.5 Hikma Pharmaceuticals PLC Recent Development
- 11.5 Pendopharm
- 11.5.1 Pendopharm Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.5.5 Pendopharm Recent Development
- 11.6 Sun Pharmaceuticals Industries Ltd.
- 11.6.1 Sun Pharmaceuticals Industries Ltd. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.6.5 Sun Pharmaceuticals Industries Ltd. Recent Development
- 11.7 Lupin Pharmaceuticals, Inc.
- 11.7.1 Lupin Pharmaceuticals, Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.7.5 Lupin Pharmaceuticals, Inc. Recent Development
- 11.8 Pfizer, Inc.
- 11.8.1 Pfizer, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.8.5 Pfizer, Inc. Recent Development
- 11.9 Parnell Pharmaceuticals, Inc.
- 11.9.1 Parnell Pharmaceuticals, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.9.5 Parnell Pharmaceuticals, Inc. Recent Development
- 11.10 Acacia Pharma
- 11.10.1 Acacia Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Products Offered
- 11.10.5 Acacia Pharma Recent Development
- 11.11 OraCoat
12 Future Forecast
- 12.1 Xerostomia (Dry Mouth) Therapeutics Market Forecast by Regions
- 12.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Xerostomia (Dry Mouth) Therapeutics Market Forecast by Product
- 12.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Xerostomia (Dry Mouth) Therapeutics Market Forecast by End User
- 12.4 North America Xerostomia (Dry Mouth) Therapeutics Forecast
- 12.5 Europe Xerostomia (Dry Mouth) Therapeutics Forecast
- 12.6 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Forecast
- 12.7 Central & South America Xerostomia (Dry Mouth) Therapeutics Forecast
- 12.8 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Xerostomia (Dry Mouth) Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Xerostomia (Dry Mouth) Therapeutics . Industry analysis & Market Report on Xerostomia (Dry Mouth) Therapeutics is a syndicated market report, published as Global Xerostomia (Dry Mouth) Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Xerostomia (Dry Mouth) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
